Alzheimer’s: Not Just a Disease for Older Adults

Alzheimer’s disease is thought of as a condition affecting seniors. But early-onset Alzheimer’s is a devastating diagnosis for people in their primary earning and family-building years.

1:00 PM

Author | Michigan Alzheimer’s Disease Center

Most of us know Alzheimer's disease, the most common type of dementia and sixth-leading cause of death in the U.S., as a condition that affects older adults.

SEE ALSO: Coping Strategies for Lewy Body Dementia Caregivers: A First-Person Story

But as the country mourns Pat Summitt, the winningest college basketball coach in history, early-onset Alzheimer's, the form of the disease Summitt had for the last five years of her life, has entered the spotlight.

Symptoms of early-onset Alzheimer's, defined as any stage of the disease that strikes a person before age 65, affect people in their 30s, 40s or 50s, constituting up to 5 percent of those with the disease. This means those newly diagnosed are in their primary earning years, in the midst of building families and enjoying the hard-earned wisdom of midlife experience and creative expression.

These are sobering thoughts. It is widely accepted that old age and memory loss go hand in hand. But memory loss among younger adults is quickly attributed to stress, depression or lack of sleep, meaning it often takes longer to get a correct diagnosis. 

Caring for someone with early-onset dementia

Dementia has long been associated with adults past retirement age, after children are raised and careers forged and celebrated. But as early-onset cases show us, this idea is not always reality.

With this in mind, many shudder at the thought of dementia and wince at the idea of a person in his or her prime diagnosed with Alzheimer's or a related dementia.

But, thankfully, we know more now and aim to shift the paradigm from one of fear to understanding through compassion and advocacy.

The National Alzheimer's Association launched the program ACT on Alzheimer's to designate dementia-friendly communities so everyone can better support individuals with the disease and their families.

In recent years, as more public figures have been diagnosed with Alzheimer's disease, Parkinson's disease and Lewy body dementia, these individuals have generously increased awareness, contributed to the creative landscape of media outreach and helped to improve research funding. Still, we must continue to ask how these efforts translate to our communities, and the way we are equipped as individuals and families to respond meaningfully and advocate for those who are living with the symptoms now.

Finding support for caregivers and patients

With the devastating news of dementia comes the staggering realization that all networks of support and normal access to community, like work, social and family life, are challenged and may diminish or disappear altogether. While we continue to work toward a cure, we must create ways to help individuals and families in the midst of diagnosis to keep their connections and to remain included in community and civic settings.

SEE ALSO: How Therapy Animals Help Those Living with Dementia

If you or someone in your family has the condition, remember: You are not alone. It is believed that at least 200,000 people in America under the age of 65 have early-onset Alzheimer's disease. There are resources to help you. There are resources and networks created to prevent isolation and improve your access to care and a community of peers. 

As with any dementia diagnosis, it's beneficial to join a community for support, discussion and education, such as our Elderberry Club at the University of Michigan, just for women with early-onset memory loss. The members of Elderberry Club seek a creative and connected life. They have published poetry, created a traveling art gallery, volunteer together and make friends in a safe space. You can find information about local support groups and programs in your area through the Alzheimer's Association.

If we are to truly help families living with early-onset Alzheimer's, we need to simultaneously change the policies and develop a comprehensive national action plan. One resource we recommend is the Dementia-Friendly Communities toolkit from ACT on Alzheimer's.

This is the predominant public health dilemma of our day, with Alzheimer's and other dementias taking more lives than breast cancer and prostate cancer combined.

Getting involved, whether or not you are directly affected by Alzheimer's disease today, is vital to improving the lives of those with the disease in the future.


More Articles About:

Brain Health Alzheimer's Disease Neurodegenerative Disorder Neurological (Brain) Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Health Lab

Family Connection Motivates Alzheimer’s Research

A Michigan Medicine scientist explains her drive to find treatments for Alzheimer’s, plus what others should know about the disease.
Health Lab

7 Lessons I Learned as a Lewy Body Dementia Support Group Facilitator

Most people aren’t familiar with the second most common form of dementia. What all patients and caregivers should know.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.
Minding memory above a microphone on a blue background
Minding Memory

Can Your Voice Reveal Early Signs of Alzheimer’s?

In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders. Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease. The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.
Cole, wearing sunglasses and a purple Calming the Storm t-shirt with a rainbow, is seated on a blanket outdoors and holding a Mott teddy bear.
Philanthropy News

A pediatric epilepsy fundraiser that changes lives

Your support of Calming the Storm advances pediatric epilepsy research and patient care programs. There are many ways you can contribute to make a difference for so many children and families.
Doctor performing a test
News Release

Michigan Alzheimer's Disease Research Center receives $22M to advance efforts statewide

NIH renews $22M for Michigan Alzheimer's Disease Research Center, supporting a first-of-its-kind statewide partnership and dementia research.